January 15, 2026 - PRESSADVANTAGE - Lucent Vision has published a new educational resource titled “What Practice Offers ...

In addition, AgomAb has a lung-restricted ALK5 inhibitor (AGMB-447) in early human testing with aspirations to develop it for ...

SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...

SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...

Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both unveiled their intentions to go public, in ...

BVI, a global leader in the ophthalmic device market, announced today the appointment of Jim Hollingshead as President & ...

Two more biopharma companies—the hair-growth specialist Veradermics and cancer-focused Eikon Therapeutics—have announced ...

Dr Pali Lehohla critiques the South African matric pass rate, revealing it as a deceptive metric that obscures deeper ...

Five diagnostic tools are critical to assist surgeons in choosing the most appropriate IOL for the patient and maintaining clinic flow and efficiency, according to a presenter. At Hawaiian Eye 2026, ...

BVI, a global leader in the ophthalmic device market, announced today the appointment of Jim Hollingshead as President & Chief Executive Officer. Hollingshead ...

What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” explains Dr. Levenson. These include: Blurry or cloudy vision that makes ...

In an age where cancel culture dominates the narrative, Teyana Taylor’s reflections offer an alternative an encouraging ...